Insider Trading & Ownership - Rovaldi Christopher

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Rovaldi Christopher
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-04-06
Sale
2022-04-08
4:21 pm
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
1,728$65$112,3208,002
(Direct)
View
2022-04-01
Sale
2022-04-05
4:31 pm
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
864$57.49$49,6759,730
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-13
Option Award
2024-02-15
8:38 pm
N/A
2034-02-12
Keros Therapeutics Inc.KROSRovaldi Christopher
CHIEF OPERATING OFFICER
150,000$0150,000
(Direct)
View
2023-02-16
Option Award
2023-02-17
4:19 pm
N/A
2033-02-15
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
100,000$0100,000
(Direct)
View
2022-04-06
Exercise
2022-04-08
4:21 pm
N/A
2030-04-07
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
1,728$08,002
(Direct)
View
2022-04-06
Exercise
2022-04-08
4:21 pm
N/A
N/A
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
1,728$168,002
(Direct)
View
2022-04-01
Exercise
2022-04-05
4:31 pm
N/A
2030-04-07
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
864$09,730
(Direct)
View
2022-04-01
Exercise
2022-04-05
4:31 pm
N/A
N/A
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
864$169,730
(Direct)
View
2022-02-01
Option Award
2022-02-03
4:45 pm
N/A
2032-01-31
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
100,000$0100,000
(Direct)
View

Ownership
2022-02-03
4:37 pm
N/A
2029-09-18
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
0$032,898
(Direct)
View